Literature DB >> 12876233

Cerebral vasomotor reactivity testing in head injury: the link between pressure and flow.

E W Lang1, J Lagopoulos, J Griffith, K Yip, A Yam, Y Mudaliar, H M Mehdorn, N W C Dorsch.   

Abstract

BACKGROUND: It has been suggested that a moving correlation index between mean arterial blood pressure and intracranial pressure, called PRx, can be used to monitor and quantify cerebral vasomotor reactivity in patients with head injury.
OBJECTIVES: To validate this index and study its relation with cerebral blood flow velocity and cerebral autoregulation; and to identify variables associated with impairment or preservation of cerebral vasomotor reactivity.
METHODS: The PRx was validated in a prospective study of 40 head injured patients. A PRx value of less than 0.3 indicates intact cerebral vasomotor reactivity, and a value of more than 0.3, impaired reactivity. Arterial blood pressure, intracranial pressure, mean cerebral perfusion pressure, and cerebral blood flow velocity, measured bilaterally with transcranial Doppler ultrasound, were recorded. Dynamic cerebrovascular autoregulation was measured using a moving correlation coefficient between arterial blood pressure and cerebral blood flow velocity, the Mx, for each cerebral hemisphere. All variables were compared in patients with intact and impaired cerebral vasomotor reactivity.
RESULTS: No correlation between arterial blood pressure or cerebral perfusion pressure and cerebral blood flow velocity was seen in 19 patients with intact cerebral vasomotor reactivity. In contrast, the correlation between these variables was significant in 21 patients with impaired cerebral vasomotor reactivity, whose cerebral autoregulation was reduced. There was no correlation with intracranial pressure, arterial blood pressure, cerebral perfusion pressure, or interhemispheric cerebral autoregulation differences, but the values for these indices were largely within normal limits.
CONCLUSIONS: The PRx is valid for monitoring and quantifying cerebral vasomotor reactivity in patients with head injury. This intracranial pressure based index reflects changes in cerebral blood flow and cerebral autoregulatory capacity, suggesting a close link between blood flow and intracranial pressure in head injured patients. This explains why increases in arterial blood pressure and cerebral perfusion pressure may be useful for reducing intracranial pressure in selected head injured patients (those with intact cerebral vasomotor reactivity).

Entities:  

Mesh:

Year:  2003        PMID: 12876233      PMCID: PMC1738604          DOI: 10.1136/jnnp.74.8.1053

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  28 in total

1.  Characterization of cerebral hemodynamic phases following severe head trauma: hypoperfusion, hyperemia, and vasospasm.

Authors:  N A Martin; R V Patwardhan; M J Alexander; C Z Africk; J H Lee; E Shalmon; D A Hovda; D P Becker
Journal:  J Neurosurg       Date:  1997-07       Impact factor: 5.115

2.  Pressure-induced myogenic responses in human isolated cerebral resistance arteries.

Authors:  S J Wallis; J Firth; W R Dunn
Journal:  Stroke       Date:  1996-12       Impact factor: 7.914

3.  Testing of cerebral autoregulation in head injury by waveform analysis of blood flow velocity and cerebral perfusion pressure.

Authors:  M Czosnyka; E Guazzo; V Iyer; P Kirkpatrick; P Smielewski; H Whitehouse; J D Pickard
Journal:  Acta Neurochir Suppl (Wien)       Date:  1994

4.  Autoregulatory vasodilation of parenchymal vessels is impaired during cerebral vasospasm.

Authors:  K D Yundt; R L Grubb; M N Diringer; W J Powers
Journal:  J Cereb Blood Flow Metab       Date:  1998-04       Impact factor: 6.200

5.  The effect of changes in cerebral perfusion pressure upon middle cerebral artery blood flow velocity and jugular bulb venous oxygen saturation after severe brain injury.

Authors:  K H Chan; J D Miller; N M Dearden; P J Andrews; S Midgley
Journal:  J Neurosurg       Date:  1992-07       Impact factor: 5.115

6.  Phase relationship between cerebral blood flow velocity and blood pressure. A clinical test of autoregulation.

Authors:  R R Diehl; D Linden; D Lücke; P Berlit
Journal:  Stroke       Date:  1995-10       Impact factor: 7.914

7.  Orthostatic changes of cerebral blood flow velocity in patients with autonomic dysfunction.

Authors:  M Daffertshofer; R R Diehl; G U Ziems; M Hennerici
Journal:  J Neurol Sci       Date:  1991-07       Impact factor: 3.181

Review 8.  Intracranial pressure. Monitoring and management.

Authors:  E W Lang; R M Chesnut
Journal:  Neurosurg Clin N Am       Date:  1994-10       Impact factor: 2.509

9.  Monitoring of cerebral autoregulation in head-injured patients.

Authors:  M Czosnyka; P Smielewski; P Kirkpatrick; D K Menon; J D Pickard
Journal:  Stroke       Date:  1996-10       Impact factor: 7.914

10.  Continuous assessment of the cerebral vasomotor reactivity in head injury.

Authors:  M Czosnyka; P Smielewski; P Kirkpatrick; R J Laing; D Menon; J D Pickard
Journal:  Neurosurgery       Date:  1997-07       Impact factor: 4.654

View more
  16 in total

1.  Early blood pressure management for endovascular therapy in acute ischemic stroke: A review of the literature.

Authors:  Bin Han; Xuan Sun; Xu Tong; Baixue Jia; Dapeng Mo; Xiaoqing Li; Gang Luo; Zhongrong Miao
Journal:  Interv Neuroradiol       Date:  2020-06-11       Impact factor: 1.610

Review 2.  Direct cerebral oxygenation monitoring--a systematic review of recent publications.

Authors:  Erhard W Lang; Jamin M Mulvey; Yugan Mudaliar; Nicholas W C Dorsch
Journal:  Neurosurg Rev       Date:  2007-01-13       Impact factor: 3.042

3.  Temporal changes in cerebral tissue oxygenation with cerebrovascular pressure reactivity in severe traumatic brain injury.

Authors:  B T Ang; J Wong; K K Lee; E Wang; I Ng
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-10-06       Impact factor: 10.154

Review 4.  Neuromonitoring in the intensive care unit. I. Intracranial pressure and cerebral blood flow monitoring.

Authors:  Anuj Bhatia; Arun Kumar Gupta
Journal:  Intensive Care Med       Date:  2007-05-24       Impact factor: 17.440

Review 5.  Cerebral perfusion and blood-brain barrier assessment in brain trauma using contrast-enhanced near-infrared spectroscopy with indocyanine green: A review.

Authors:  Mario Forcione; Antonio M Chiarelli; David J Davies; David Perpetuini; Piotr Sawosz; Arcangelo Merla; Antonio Belli
Journal:  J Cereb Blood Flow Metab       Date:  2020-04-28       Impact factor: 6.200

6.  One-minute dynamic cerebral autoregulation in severe head injury patients and its comparison with static autoregulation. A transcranial Doppler study.

Authors:  Corina Puppo; Lucía López; Elia Caragna; Alberto Biestro
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

Review 7.  Therapeutic hypothermia for traumatic brain injury.

Authors:  L A Urbano; Mauro Oddo
Journal:  Curr Neurol Neurosci Rep       Date:  2012-10       Impact factor: 5.081

8.  Further Controversies About Brain Tissue Oxygenation Pressure-Reactivity After Traumatic Brain Injury.

Authors:  Morten Andresen; Joseph Donnelly; Marcel Aries; Marianne Juhler; David Menon; Pja Hutchinson; Peter Smielewski
Journal:  Neurocrit Care       Date:  2018-04       Impact factor: 3.210

9.  Optimal Cerebral Perfusion Pressure Management at Bedside: A Single-Center Pilot Study.

Authors:  Celeste Dias; Maria João Silva; Eduarda Pereira; Elisabete Monteiro; Isabel Maia; Silvina Barbosa; Sofia Silva; Teresa Honrado; António Cerejo; Marcel J H Aries; Peter Smielewski; José-Artur Paiva; Marek Czosnyka
Journal:  Neurocrit Care       Date:  2015-08       Impact factor: 3.210

10.  Impaired cerebrovascular reactivity after acute traumatic brain injury can be detected by wavelet phase coherence analysis of the intracranial and arterial blood pressure signals.

Authors:  Per Kvandal; Lawrence Sheppard; Svein A Landsverk; Aneta Stefanovska; Knut A Kirkeboen
Journal:  J Clin Monit Comput       Date:  2013-06-08       Impact factor: 2.502

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.